Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: Results of a Diabetes Research in Children Network (DirecNet) Study

H. Peter Chase, Rosanna Fiallo-Scharer, Jennifer H. Fisher, Barbara Tallant, Eva Tsalikian, Michael J. Tansey, Linda F. Larson, Julie Coffey, Tim Wysocki, Nelly Mauras, Larry A. Fox, Keisha Bird, Kelly L. Lofton, Bruce A. Buckingham, Darrell M. Wilson, Jennifer M. Block, Paula Clinton, Stuart A. Weinzimer, William V. Tamborlane, Elizabeth A. DoyleKristin Sikes, Roy W. Beck, Katrina J. Ruedy, Craig Kollman, Dongyuan Xing, Cynthia R. Silvester, Dorothy M. Becker, Christopher Cox, Christopher M. Ryan, Neil H. White, Perrin C. White, Michael W. Steffes, Jean M. Bucksa, Maren L. Nowicki, Carol A. Van Hale, Gilman D. Grave, Barbara Linder, Karen K. Winer

Research output: Contribution to journalArticlepeer-review

110 Scopus citations


Background: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) high-performance liquid chromatography (HPLC) method for measuring hemoglobin A1c (HbA1c) serves as a reference standard against which other assays are compared. The DCA 2000® + Analyzer (Bayer Inc., Tarrytown, NY, USA), which uses an immunoassay, is a very popular device for measuring HbA1c levels in pediatric diabetes practices. Objective: To determine how HbA1c values measured with the DCA 2000 in a multisite, pediatric diabetes clinic setting compare with corresponding HbA1c values measured in the DCCT/EDIC laboratory. Design/Methods: To examine this question, the Diabetes Research in Children Network (DirecNet) used the DCA 2000 in five clinical centers to measure baseline HbA1c levels in 200 youth with type 1 diabetes mellitus (T1DM) (aged 12.5 ± 2.8 yr) who were participating in an outpatient clinical trial. At the same visit, an additional blood sample was obtained, refrigerated, and shipped to the DCCT/EDIC central laboratory for determination of HbA1c values. Results: The central laboratory HbA1c value averaged 8.0 ± 0.9% (mean ± SD), with a median (25th and 75th quartiles) of 7.8% (7.3 and 8.5%, respectively). The DCA 2000 HbA1c values were strongly correlated (r = 0.94, p < 0.001), but significantly higher than DCCT/EDIC central laboratory values with a mean difference of +0.2% (95% confidence interval +0.14 to 0.23%, p < 0.001). There was some variation in the differences between DCA 2000 and central laboratory values at the five clinical centers (p < 0.001) with mean differences ranging between 0.0 and 0.3%, but differences between the two methods did not vary significantly by age or gender. Conclusion: Measurements of HbA1c by the DCA 2000 compare favorably with the DCCT/EDIC central laboratory method, albeit with slightly higher values.

Original languageEnglish (US)
Pages (from-to)13-16
Number of pages4
JournalPediatric Diabetes
Issue number1
StatePublished - Mar 2005


  • Assay
  • Child
  • Diabetes mellitus
  • HbA1c
  • Type 1

ASJC Scopus subject areas

  • Internal Medicine
  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: Results of a Diabetes Research in Children Network (DirecNet) Study'. Together they form a unique fingerprint.

Cite this